Jump to content

Zolertine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DePiep (talk | contribs) at 21:28, 7 July 2015 (Chembox: rm/replace deprecated params. Fix unknown parameters (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Zolertine
Names
IUPAC name
1-Phenyl-4-[2-(tetrazol-5-yl)ethyl]piperazine
Identifiers
3D model (JSmol)
ChemSpider
  • InChI=1S/C13H18N6/c1-2-4-12(5-3-1)19-10-8-18(9-11-19)7-6-13-14-16-17-15-13/h1-5H,6-11H2,(H,14,15,16,17)
    Key: XTTHMUYLNLEJRS-UHFFFAOYSA-N
  • InChI=1/C13H18N6/c1-2-4-12(5-3-1)19-10-8-18(9-11-19)7-6-13-14-16-17-15-13/h1-5H,6-11H2,(H,14,15,16,17)
    Key: XTTHMUYLNLEJRS-UHFFFAOYAE
  • C1CN(CCN1CCC2=NNN=N2)C3=CC=CC=C3
Properties
C13H18N6
Molar mass 258.329 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Zolertine is an alpha-adrenoceptor antagonist.[1]

References

  1. ^ Ibarra, M; Hong, E; Villalobos-Molina, R (2000). "The alpha-adrenoceptor antagonist, zolertine, inhibits alpha1D- and alpha1A-adrenoceptor-mediated vasoconstriction in vitro". Journal of autonomic pharmacology. 20 (3): 139–45. PMID 11193002.